Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (251-260 of 310) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell TumorsAditya Bagrodia, Byron H Lee, William Lee, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
Neuro-Oncology|September 2, 2025
Genomics correlates of brain metastasis and progression in colorectal cancerChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
Cancer Cell|August 30, 2024
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerCaitlin A McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Discovery|January 12, 2020
Characteristics and Outcome of <i>AKT1</i> <sup>E17K</sup>-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic RegistryLillian M Smyth, Qin Zhou, Bastien Nguyen, et al.
Hepatology (Baltimore, Md.)|March 25, 2021
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaThomas Boerner, Esther Drill, Linda M Pak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical PhenotypeMaeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Pageof 31

Showing results (251-260 of 310) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell TumorsAditya Bagrodia, Byron H Lee, William Lee, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
Neuro-Oncology|September 2, 2025
Genomics correlates of brain metastasis and progression in colorectal cancerChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
Cancer Cell|August 30, 2024
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancerCaitlin A McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Discovery|January 12, 2020
Characteristics and Outcome of <i>AKT1</i> <sup>E17K</sup>-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic RegistryLillian M Smyth, Qin Zhou, Bastien Nguyen, et al.
Hepatology (Baltimore, Md.)|March 25, 2021
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaThomas Boerner, Esther Drill, Linda M Pak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical PhenotypeMaeve A Lowery, Emmet J Jordan, Olca Basturk, et al.
JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Pageof 31